Tasigna Capsules 150mg by Novartis Pharma features Nilotinib hydrochloride hydrate, indicated for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). This 150mg 1 capsule formulation is identified by YJ code 4291021M2027.
Tasigna Capsules 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
